BSECompany Update29 Sept 2026 · 29 Sept 2026, 11:26 pm

Intimation under regulation 30 of LODR Regulation - Change in Management pursuant to approval of members at 33rd Annual General Meeting of the Company.

Kimia Biosciences Ltd · 530313

✦ AI SummaryMgmt Change

Kimia Biosciences Ltd has announced changes in its board of directors following the approval of its 33rd Annual General Meeting. The company has appointed four new directors, including Mr. Amulya Kumar Nayak, Ms. Reema Goyal, Mr. Avinash Prabhat, and Mr. Sameer Goel, who will retire by rotation.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern5/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment4/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Kimia Biosciences Ltd - 530313 - Announcement under Regulation 30 (LODR)-Change in Management

Attachments (1)

📄

5806304b-9bdb-4310-b376-0cdd30cd424f.pdf

pdf

Download →
View document text
DATE- 29.09.2026 The Manager – Listing Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400001 Scrip Code: 530313 Subject: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Change in Management pursuant to approval of Members at the 33rd Annual General Meeting. Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the 33rd Annual General Meeting (“AGM”) of the Members of Kimia Biosciences Limited (“Company”) was held on Monday, 28 September 2026 at 3:10 P.M. through Video Conferencing / Other Audio-Visual Means. We further inform that the Members of the Company, inter alia, approved the following resolutions relating to the composition of the Board of Directors: 1. To appoint a director in place of Mr. Sameer Goel (DIN: 00161786), Director, who retires by rotation, and being eligible, offers himself for re-appointment pursuant to the provisions of Section 152 of the Companies Act, 2013. 2. To approve appointment of Mr. Amulya Kumar Nayak (DIN: 11667557) as Director retire by rotation. 3. To approve appointment of Ms. Reema Goyal (DIN: 11266730) as Independent & Non- Executive Woman Director. 4. To approve appointment of Mr. Avinash Prabhat (DIN:10997441) as independent & Non Executive Director. The brief particulars/details of the Directors appointed/re-appointed, as required under Regulation 30 read with Schedule III of the SEBI LODR Regulations, are enclosed as Annexure A to this letter. We further confirm that none of the above Directors is debarred from holding the office of KIMA BIOSCIENCES LIMITED ed 0tie/wor Vil.le h0l Dr Lk 6gel.%.2.. fl. 4964/4.44496.42044 compliance.kimiabiosciences@gmail.com | info@kimiabiosciences.com | www.kimiabiosciences.com | CIN No.:L24239HR1993PLC032120 Director by virtue of any order of SEBI or any other such authority. The above information is being submitted for your information and records. Thanking you, For Kimia Biosciences Limited Abhishek Kumar Pandey Company Secretary & Compliance Officer Membership No.: F12457 Date: 29 September 2026 Place: Gurugram, Haryana KIMA BIOSCIENCES LIMITED ed 0tie/wor Vil.le h0l Dr Lk 6gel.%.2.. fl. 4964/4.44496.42044 compliance.kimiabiosciences@gmail.com | info@kimiabiosciences.com | www.kimiabiosciences.com | CIN No.:L24239HR1993PLC032120 ANNEXURE- A Details of Directors Appointed / Re-appointed Particulars Mr. Amulya Ms. Reema Mr. Avinash Mr. Sameer Kumar Nayak Goyal Prabhat Goel Reason for Appointment/ Appointment as Appointment as Re- change Regularisation Non-Executive Non-Executive appointment as as Director Independent Independent Director liable Woman Director Director to retire by rotation Date of 28 September 4 April 2026, 4 April 2026, 28 September appointment / 2026 pursuant to pursuant to 2026 re-appointment approval of approval of Members at Members at AGM AGM Term of Liable to retire Five consecutive Five Liable to retire appointment by rotation years, from 4 consecutive by rotation April 2026 to 3 years, from 4 April 2031 April 2026 to 3 April 2031 DIN 11667557 11266730 10997441 00161786 Category Non-Executive Non-Executive Non-Executive Managing Director Independent Independent Director / Woman Director Director Director Brief Profile Given in Given in Given in Given in Annexure-I Annexure-II Annexure-III Annexure-IV Disclosure of None None None None relationships between Directors inter- KIMA BIOSCIENCES LIMITED ed 0tie/wor Vil.le h0l Dr Lk 6gel.%.2.. fl. 4964/4.44496.42044 compliance.kimiabiosciences@gmail.com | info@kimiabiosciences.com | www.kimiabiosciences.com | CIN No.:L24239HR1993PLC032120 Shareholding in None None None 74.94% the Company Debarment by He is not she is not He is not He is not SEBI / other debarred debarred debarred debarred authority ANNEXURE-I Brief Resume / Expertise Mr. Amulya Kumar Nayak is a seasoned finance and accounts professional with more than 32 years of experience in finance, accounts, taxation, audit, MIS, budgeting, banking and commercial functions. He has worked with reputed organisations including Punj Lloyd Ltd., GTL Ltd., Pepsi Foods Ltd., Sterling Holiday Resorts and others. He possesses strong expertise in ERP systems, financial controls, statutory compliance and corporate finance. ANNEXURE-II Brief Resume / Expertise Ms. Reema Goyal, aged 31 years, is a Company Secretary in Practice and B.Com graduate. She has more than five years of experience in Corporate Law, Companies Act, SEBI Laws and other law-related matters. She has knowledge of advisory services in corporate law, secretarial compliance, governance advisory, corporate restructuring and regulatory approvals. KIMA BIOSCIENCES LIMITED ed 0tie/wor Vil.le h0l Dr Lk 6gel.%.2.. fl. 4964/4.44496.42044 compliance.kimiabiosciences@gmail.com | info@kimiabiosciences.com | www.kimiabiosciences.com | CIN No.:L24239HR1993PLC032120 ANNEXURE-III Brief Resume / Expertise Mr. Avinash Prabhat, aged 30 years, is a Company Secretary by profession and B.Com graduate. He has more than five years of experience in Corporate Law, Companies Act, SEBI Laws and other law related matters. He contributes to governance, statutory compliance, risk management and stakeholder oversight. ANNEXURE-IV Brief Resume / Expertise Mr. Sameer Goel is a Delhi University Commerce graduate and has extensive experience in the Indian pharmaceutical/API sector, with expertise in business development, product development, strategic marketing and operations management. He is a founder of Kimia Biosciences Limited and has substantial experience in the pharmaceutical APIs business. Thanking you, For Kimia Biosciences Limited Abhishek Kumar Pandey Company Secretary & Compliance Officer Membership No.: F12457 Date: 29 September 2026 Place: Gurugram, Haryana KIMA BIOSCIENCES LIMITED ed 0tie/wor Vil.le h0l Dr Lk 6gel.%.2.. fl. 4964/4.44496.42044 compliance.kimiabiosciences@gmail.com | info@kimiabiosciences.com | www.kimiabiosciences.com | CIN No.:L24239HR1993PLC032120